StockData
Xencor Inc logo

Xencor Inc (XNCR) stock

XNCRNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 4, 2026Score 5/30194% above fair value
$34.39−0.11 (-0.32%)

Close on Nov 18, 2026Market cap $2.56BP/E –Yield –

Xencor pe ratio

The price-to-earnings ratio is the share price divided by diluted earnings per share over the trailing twelve months.

Xencor's pe ratio was 70.0× on Jan 31, 2023, against 106.9× a year earlier. Over the last 3 years it ranged from 12.6× to 106.9×, with a median of 52.6×.

PE Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2023Jan 31, 202370.0×+14.6
2022Dec 30, 202255.4×−51.5
2021Oct 29, 2021106.9×+43.4
2020Apr 30, 202063.5×+6.2
2019Dec 31, 201957.3×−2.6
2017Jul 31, 201759.9×+32.5
2016Dec 30, 201627.4×–

More Xencor figures

See a number that looks wrong?